SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001615774-16-005470
Filing Date
2016-05-16
Accepted
2016-05-16 17:06:04
Documents
58
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q s103209_10q.htm 10-Q 449498
2 EXHIBIT 10-1 s103209_ex10-1.htm EX-10.1 209963
3 EXHIBIT 10.2 s103209_ex10-2.htm EX-10.2 132188
4 EXHIBIT 31.1 s103209_ex31-1.htm EX-31.1 9364
5 EXHIBIT 31.2 s103209_ex31-2.htm EX-31.2 9456
6 EXHIBIT 32.1 s103209_ex32-1.htm EX-32.1 4185
7 EXHIBIT 32.2 s103209_ex32-2.htm EX-32.2 4007
8 GRAPHIC tpg05.jpg GRAPHIC 74652
9 GRAPHIC tlogo1.jpg GRAPHIC 11916
10 GRAPHIC tlogo12.jpg GRAPHIC 13306
11 GRAPHIC tlogo24.jpg GRAPHIC 11878
  Complete submission text file 0001615774-16-005470.txt   3076926

Data Files

Seq Description Document Type Size
12 XBRL INSTANCE FILE heb-20160331.xml EX-101.INS 401180
13 XBRL SCHEMA FILE heb-20160331.xsd EX-101.SCH 27105
14 XBRL CALCULATION FILE heb-20160331_cal.xml EX-101.CAL 38752
15 XBRL DEFINITION FILE heb-20160331_def.xml EX-101.DEF 129935
16 XBRL LABEL FILE heb-20160331_lab.xml EX-101.LAB 254166
17 XBRL PRESENTATION FILE heb-20160331_pre.xml EX-101.PRE 202367
Mailing Address 1617 JFK BLVD, SUITE #500 ONE PENN CENTER PHILADELPHIA PA 19103
Business Address 1617 JFK BLVD, SUITE #500 ONE PENN CENTER PHILADELPHIA PA 19103 215-988-0080
HEMISPHERX BIOPHARMA INC (Filer) CIK: 0000946644 (see all company filings)

IRS No.: 520845822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-27072 | Film No.: 161654971
SIC: 2836 Biological Products, (No Diagnostic Substances)